Moncla et al., 2005 - Google Patents
Why nonoxynol-9 may have failed to prevent acquisition of Neisseria gonorrhoeae in clinical trialsMoncla et al., 2005
- Document ID
- 17855924273529077748
- Author
- Moncla B
- Hillier S
- Publication year
- Publication venue
- Sexually transmitted diseases
External Links
Snippet
Objectives: To understand why clinical trials failed to demonstrate efficacy of nonoxynol-9 in preventing gonorrhea. Goal: To test the hypothesis that nonoyxnol-9 failed to prevent acquisition of Neisseria gonorrhoeae because most isolates are resistant to killing by …
- 229920004918 nonoxynol-9 0 title abstract description 77
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N-C(=NH)-NH2), isourea (N=C(OH)-NH2), isothiourea (-N=C(SH)-NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hillier et al. | In vitro and in vivo: the story of nonoxynol 9 | |
Aldunate et al. | Vaginal concentrations of lactic acid potently inactivate HIV | |
Stafford et al. | Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects | |
KR100336183B1 (en) | Virus killing, bactericidal and spermicide suppositories | |
Buvé et al. | The vaginal microbiota and susceptibility to HIV | |
GREAVES et al. | Clindamycin versus metronidazole in the treatment of bacterial vaginosis | |
Zeitlin et al. | Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models | |
Sutyak et al. | Spermicidal activity of the safe natural antimicrobial peptide subtilosin | |
Thormar et al. | Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro. | |
Bosserman et al. | Utility of antimicrobial susceptibility testing in Trichomonas vaginalis–infected women with clinical treatment failure | |
Zaneveld et al. | Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly (sodium 4-styrenesulfonate) | |
Patton et al. | Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina) | |
Weber et al. | Chemical condoms’ for the prevention of HIV infection: evaluation of novel agents against SHIV89. 6PDin vitro and in vivo | |
Brittingham et al. | The antimicrobial effect of boric acid on Trichomonas vaginalis | |
Achilles et al. | Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis | |
CN113613733A (en) | Topical, isotonic compositions for genital use | |
Clarke et al. | Microflora changes with the use of a vaginal microbicide | |
Patton et al. | Rectal applications of nonoxynol-9 cause tissue disruption in a monkey model | |
Stafford et al. | A Placebo-controlled, Double-blind Prospective Study in Healthy Female Volunteers of Dextrin Sulphate Gel:: A Novel Potential Intravaginal Virucide | |
Moncla et al. | Testing of viscous anti-HIV microbicides using Lactobacillus | |
Watts et al. | The effects of three nonoxynol-9 preparations on vaginal flora and epithelium | |
Stone et al. | Vaginal microbicides for preventing the sexual transmission of HIV | |
Moncla et al. | Why nonoxynol-9 may have failed to prevent acquisition of Neisseria gonorrhoeae in clinical trials | |
US20050238728A1 (en) | Synergistic topically applied personal hygiene product | |
Bukusi et al. | Topical penile microbicide use by men to prevent recurrent bacterial vaginosis in sex partners: a randomized clinical trial |